|
| Irradiated | The component has been irradiated and the expiry has been reduced to 14 days post-irradiation. The component will also have a RADSURE label to indicate that irradiation was performed. |
| Irradiated NEONATAL | The component has been ordered for a neonatal transfusion and has been irradiated. The expiry has been reduced to 48 hours post-irradiation. The component will also have a RADSURE label to indicate that irradiation was performed. |
| Hyper concentrated | The supernatant has been removed from the red cell component and the expiry reduced to 48 hours post-hyper concentration. |
| Hyper concentrated Platelets | The supernatant has been removed from the platelet component and the expiry reduced to 6 hours post-hyper concentration. |
| Directed | A directed component is one that has been collected from a selected donor known to the patient, usually a close relative of the patient. The component is reserved for that patient. Such components are always irradiated. They will also have a blue label with the patient details attached. |
| Hyper concentrated/Irradiated | The supernatant has been removed and the component has been irradiated. The expiry is reduced to 24 hours post-hyperconcentration/Irradiation. |
| Irradiated for IUT | The component has been ordered for an intrauterine transfusion and has been irradiated. The expiry is reduced to 24 hours post-irradiation. |
| For Intrauterine transfusion | The component has been ordered for an Intrauterine transfusion. Therefore the expiry has been reduced to 48 hours post-application of the modifier (eg. washing). |
| CMV Negative | The originating donor sample/donation has been tested for CMV antibody and is negative. |
| Not NAT Tested | Due to extenuating circumstances, (e.g, machine failure or specific clinical demand) this component has been released without nucleic acid technology (NAT) testing being performed. A disclaimer form will accompany these components. |
| Low Anti-T | The originating donor sample/donation has been tested and Anti-T was not detected. |
| IgA Deficient | The originating donor sample/donation has been tested and is IgA deficient. |
| Suitable for Research | The component is deemed unsuitable for clinical use, but may be used for research purposes. (Note that this will never be issued to a clinical customer for transfusion). |
| Secretor Plasma Le(b+) | The component is from a Le (a-b+) donor and, as such, is suitable for absorption of Lewis antibodies. Suitable for transfusion. |
| Not for Neonatal use | The component has been deemed unsuitable for neonatal use due to the presence of red cell antibodies (low titre only).It should not be transfused to a neonate. |
| Phenotype Reserve | The originating donor sample/donation or previous testing of donor has had an extended phenotype performed and forms part of a panel of cells reserved for patients with antibodies or where antigen negative blood is otherwise specifically required. |
| Low Anti-A/B | The originating donor sample/donation has low levels of Anti A, B haemolysins. |
| Autol release - See disclaimer | This autologous component has tested positive for one or more viral markers but has been released upon request by the patient’s physician. A disclaimer form will accompany these components. |